WO2005117927A3 - Tissue protective cytokines with an extended therapeutic window - Google Patents

Tissue protective cytokines with an extended therapeutic window Download PDF

Info

Publication number
WO2005117927A3
WO2005117927A3 PCT/US2004/015863 US2004015863W WO2005117927A3 WO 2005117927 A3 WO2005117927 A3 WO 2005117927A3 US 2004015863 W US2004015863 W US 2004015863W WO 2005117927 A3 WO2005117927 A3 WO 2005117927A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic window
tissue protective
protective cytokines
extended therapeutic
tissue
Prior art date
Application number
PCT/US2004/015863
Other languages
French (fr)
Other versions
WO2005117927A2 (en
Inventor
Anthony Cerami
Michael Brines
Thomas Coleman
Original Assignee
Kenneth S Warren Inst Inc
Lundbeck & Co As H
Anthony Cerami
Michael Brines
Thomas Coleman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to MXPA05012515A priority Critical patent/MXPA05012515A/en
Application filed by Kenneth S Warren Inst Inc, Lundbeck & Co As H, Anthony Cerami, Michael Brines, Thomas Coleman filed Critical Kenneth S Warren Inst Inc
Priority to AU2004319797A priority patent/AU2004319797A1/en
Priority to CNA200480038280XA priority patent/CN1897960A/en
Priority to BRPI0412869-9A priority patent/BRPI0412869A/en
Priority to PCT/US2004/015863 priority patent/WO2005117927A2/en
Priority to IL172036A priority patent/IL172036A0/en
Priority to US11/283,024 priority patent/US20090258821A1/en
Publication of WO2005117927A2 publication Critical patent/WO2005117927A2/en
Priority to IS8222A priority patent/IS8222A/en
Publication of WO2005117927A3 publication Critical patent/WO2005117927A3/en
Priority to NO20062506A priority patent/NO20062506L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Abstract

Methods and uses are provided for a pharmaceutical composition with an erythropoietin or a tissue protective cytokine for protecting or restoring function to a responsive cell, tissue, organ or body part function or viability in mammals when administered outside of the therapeutic window of previously approved therapeutics.
PCT/US2004/015863 2003-05-19 2004-05-20 Tissue protective cytokines with an extended therapeutic window WO2005117927A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MXPA05012515A MXPA05012515A (en) 2003-05-19 2004-05-19 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window.
AU2004319797A AU2004319797A1 (en) 2003-05-19 2004-05-20 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
CNA200480038280XA CN1897960A (en) 2004-05-20 2004-05-20 Tissue protective cytokines for protection, restoration, and enhancement of responsive cells, tissues and organs with extended therapeutic window
BRPI0412869-9A BRPI0412869A (en) 2004-05-20 2004-05-20 use of a tissue-protecting erythropoietin or cytokine, and method for protecting or maintaining the viability of a responsive mammalian cell, tissue or organ
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window
IL172036A IL172036A0 (en) 2004-05-19 2005-11-17 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
US11/283,024 US20090258821A1 (en) 2003-05-19 2005-11-18 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
IS8222A IS8222A (en) 2004-05-20 2006-01-10 Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity
NO20062506A NO20062506L (en) 2004-05-20 2006-05-31 Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/015733 Continuation-In-Part WO2004112693A2 (en) 2003-05-19 2004-05-19 Tissue protective cytokines with an extended therapeutic window

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/283,024 Continuation US20090258821A1 (en) 2003-05-19 2005-11-18 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window

Publications (2)

Publication Number Publication Date
WO2005117927A2 WO2005117927A2 (en) 2005-12-15
WO2005117927A3 true WO2005117927A3 (en) 2006-05-11

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/015863 WO2005117927A2 (en) 2003-05-19 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Country Status (7)

Country Link
CN (1) CN1897960A (en)
AU (1) AU2004319797A1 (en)
BR (1) BRPI0412869A (en)
IL (1) IL172036A0 (en)
IS (1) IS8222A (en)
NO (1) NO20062506L (en)
WO (1) WO2005117927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader Erythropoietin (epo) application in spinal cord injury (sci) therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018978A1 (en) * 2002-06-05 2004-01-29 Campana W Marie Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
US20040209812A1 (en) * 2003-03-27 2004-10-21 Renzi Michael J. Use of erythropoietin in stroke recovery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018978A1 (en) * 2002-06-05 2004-01-29 Campana W Marie Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
US20040209812A1 (en) * 2003-03-27 2004-10-21 Renzi Michael J. Use of erythropoietin in stroke recovery

Also Published As

Publication number Publication date
WO2005117927A2 (en) 2005-12-15
NO20062506L (en) 2006-05-31
IS8222A (en) 2006-01-10
CN1897960A (en) 2007-01-17
AU2004319797A1 (en) 2006-01-12
AU2004319797A8 (en) 2008-12-11
BRPI0412869A (en) 2006-10-03
IL172036A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
WO2004112693A3 (en) Tissue protective cytokines with an extended therapeutic window
WO2004003176A3 (en) Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
PL377146A1 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
WO2005067980A3 (en) Design of therapeutics and therapeutics
WO2008045238A3 (en) Stabilized therapeutic small helical antiviral peptides
WO2006138723A3 (en) Tissue coverings bearing cutomized tissue images
WO2007149478A3 (en) Pyrazine derivatives with extended conjugation and uses thereof
WO2006097535A3 (en) Peptide agonists of the glucagon family with secretin like activity
WO2005065657A3 (en) Solid compositions of low-solubility drugs and poloxamers
HK1118011A1 (en) Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field
EP1753380A4 (en) Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
WO2006057003A3 (en) Induction of neurogenesis and stem cell therapy in combination with copolymer 1
WO2002028999A3 (en) Gene expression profiles in granulocytic cells
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
AU2003261860A1 (en) Composition for protecting organ, tissue or cell and utilization thereof
WO2007120156A3 (en) Animal models of long qt syndrome and uses thereof
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2002011724A3 (en) Neuroprotective 2-pyridinamine compositions and related methods
WO2005094364A3 (en) Iga antibody protein as a cytotoxic drug
MX2007011381A (en) Spirulin composition rich in active principles, method for obtaining same and use thereof.
WO2005117927A3 (en) Tissue protective cytokines with an extended therapeutic window
AU2003300435A1 (en) Tissue and organ preservation, protection and resuscitation
WO2004041297A3 (en) Modified cytokines for use in cancer therapy
WO2005011737A3 (en) Pharmaceutical combinations and formulations with improved stability
SI1747201T1 (en) 2H OR 3H-BENZO?áE?åINDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480038280.X

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 172036

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 12005502089

Country of ref document: PH

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2004319797

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020067000151

Country of ref document: KR

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 2004319797

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/000690

Country of ref document: MX

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: PI0412869

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 4682/CHENP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase